PMID- 22796436 OWN - NLM STAT- MEDLINE DCOM- 20121108 LR - 20220331 IS - 1525-2191 (Electronic) IS - 0002-9440 (Linking) VI - 181 IP - 3 DP - 2012 Sep TI - Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors. PG - 1069-77 LID - 10.1016/j.ajpath.2012.05.030 [doi] AB - Ossifying fibromyxoid tumor (OFMT) is a soft tissue tumor of unknown lineage. Although most cases are histologically and clinically benign, some show malignant morphological features and local recurrences are not uncommon; a few may even metastasize. In the present study, cytogenetic analysis identified different structural rearrangements of chromosome band 6p21 in tumor cells from three cases of OFMT, including one with typical, one with atypical, and one with malignant morphological features. Mapping of the 6p21 breakpoint by fluorescence in situ hybridization (FISH) indicated that the PHF1 gene was rearranged in all three cases. Further FISH, 5'-rapid amplification of cDNA ends, and RT-PCR analyses disclosed an EP400/PHF1 fusion transcript in one of the cases. Interphase FISH on tumor sections from 13 additional cases of OFMT showed rearrangement of the PHF1 locus in four of four typical, two of three atypical, and one of six malignant lesions. Thus, the PHF1 gene, previously shown to be the 3'-partner of fusion genes in endometrial stromal tumors, is also recurrently involved in the pathogenesis of OFMTs, irrespective of whether they are diagnosed as typical, atypical, or malignant lesions. The PHF1 protein interacts with the polycomb-repressive complex 2 (PRC2), which, in turn, regulates the expression of a variety of developmental genes. Thus, the results indicate that deregulation of PRC2 target genes is crucial for OFMT development. CI - Copyright (c) 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. FAU - Gebre-Medhin, Samuel AU - Gebre-Medhin S AD - Department of Clinical Genetics, University and Regional Laboratories, Lund University, Sweden. samuel.gebre-medhin@med.lu.se FAU - Nord, Karolin H AU - Nord KH FAU - Moller, Emely AU - Moller E FAU - Mandahl, Nils AU - Mandahl N FAU - Magnusson, Linda AU - Magnusson L FAU - Nilsson, Jenny AU - Nilsson J FAU - Jo, Vickie Y AU - Jo VY FAU - Vult von Steyern, Fredrik AU - Vult von Steyern F FAU - Brosjo, Otte AU - Brosjo O FAU - Larsson, Olle AU - Larsson O FAU - Domanski, Henryk A AU - Domanski HA FAU - Sciot, Raf AU - Sciot R FAU - Debiec-Rychter, Maria AU - Debiec-Rychter M FAU - Fletcher, Christopher D M AU - Fletcher CD FAU - Mertens, Fredrik AU - Mertens F LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120713 PL - United States TA - Am J Pathol JT - The American journal of pathology JID - 0370502 RN - 0 (DNA-Binding Proteins) RN - 0 (PHF1 protein, human) RN - 0 (Polycomb-Group Proteins) RN - 0 (Transcription Factors) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Base Sequence MH - Bone Neoplasms/*genetics/pathology MH - Cell Shape MH - Chromosome Breakage MH - Chromosomes, Human/genetics MH - Cytogenetic Analysis MH - DNA-Binding Proteins/*genetics MH - Female MH - Fibroma, Ossifying/*genetics/pathology MH - Gene Rearrangement/*genetics MH - Humans MH - In Situ Hybridization, Fluorescence MH - Male MH - Metaphase MH - Middle Aged MH - Molecular Sequence Data MH - Paraffin Embedding MH - Polycomb-Group Proteins MH - Polymerase Chain Reaction MH - Polymorphism, Single Nucleotide/genetics MH - Recurrence MH - Transcription Factors/*genetics EDAT- 2012/07/17 06:00 MHDA- 2012/11/09 06:00 CRDT- 2012/07/17 06:00 PHST- 2012/03/29 00:00 [received] PHST- 2012/05/21 00:00 [revised] PHST- 2012/05/30 00:00 [accepted] PHST- 2012/07/17 06:00 [entrez] PHST- 2012/07/17 06:00 [pubmed] PHST- 2012/11/09 06:00 [medline] AID - S0002-9440(12)00435-X [pii] AID - 10.1016/j.ajpath.2012.05.030 [doi] PST - ppublish SO - Am J Pathol. 2012 Sep;181(3):1069-77. doi: 10.1016/j.ajpath.2012.05.030. Epub 2012 Jul 13.